Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cytochrome P450 2C9 (Homo sapiens (Human)) | BDBM124183 (US10221160, Example 2 | US11247981, Example 2 | US...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | >6.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Viamet Pharmaceuticals, Inc. US Patent | Assay Description Mixtures of isozyme inhibitors (sulfaphenazole, tranylcypromine, and ketoconazole as specific inhibitors of isozymes 2C9, 2C19, and 3A4, respectively... | US Patent US8754227 (2014) BindingDB Entry DOI: 10.7270/Q2B56HFR | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cytochrome P450 2C9 (Homo sapiens (Human)) | BDBM124183 (US10221160, Example 2 | US11247981, Example 2 | US...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | >6.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Pooled human liver microsome suspension (20 mg/mL) was diluted with phosphate buffer to obtain a 5 mg/mL suspension. A solution of NADPH was prepared... | Citation and Details BindingDB Entry DOI: 10.7270/Q2F76GSF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cytochrome P450 2C9 (Homo sapiens (Human)) | BDBM124183 (US10221160, Example 2 | US11247981, Example 2 | US...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | >6.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Mycovia Pharmaceuticals, Inc. US Patent | Assay Description Pooled human liver microsome suspension (20 mg/mL) was diluted with phosphate buffer to obtain a 5 mg/mL suspension. A solution of NADPH was prepared... | US Patent US10221160 (2019) BindingDB Entry DOI: 10.7270/Q2736T6Q | |||||||||||
More data for this Ligand-Target Pair |